Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LIEVENS, Marc")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary courseVAN HERCK, Koen; VAN DAMME, Pierre; LIEVENS, Marc et al.Journal of medical virology. 2004, Vol 72, Num 2, pp 194-196, issn 0146-6615, 3 p.Article

Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionKESTER, Kent E; CUMMINGS, James F; JUOMPAN, Laure et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 337-346, issn 0022-1899, 10 p.Article

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique : a double blind randomised controlled phase I/IIb trial. CommentaryEPSTEIN, Judith E; APONTE, John J; LEACH, Amanda et al.Lancet (British edition). 2007, Vol 370, Num 9598, issn 0140-6736, 1523-1524, 1543-1551 [11 p.]Article

Long-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican ChildrenSACARLAL, Jahit; AIDE, Pedro; VEKEMANS, Johan et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 329-336, issn 0022-1899, 8 p.Article

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patientsKONG CHIEW TONG, Norella; BERAN, Jiri; LOPEZ DE NOVALES, Eduardo et al.Kidney international. 2005, Vol 68, Num 5, pp 2298-2303, issn 0085-2538, 6 p.Article

Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trialUMEH, Rich; OGUCHE, Stephen; CATTEAU, Gregory et al.Vaccine. 2014, Vol 32, Num 48, pp 6556-6562, issn 0264-410X, 7 p.Article

Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria ExposureOLOTU, Ally; FEGAN, Gregory; MARSH, Kevin et al.The New England journal of medicine. 2013, Vol 368, Num 12, pp 1111-1120, issn 0028-4793, 10 p.Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Malaria Treatment with Atovaquone-Proguanil in Malaria-Immune Adults : Implications for Malaria Intervention Trials and for Pre-Exposure Prophylaxis of MalariaPOLHEMUS, Mark E; REMICH, Shon; OGUTU, Bernhards et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1493-1499, issn 0066-4804, 7 p.Article

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeBEJON, Philip; LUSINGU, John; DEMOITIE, Marie-Ange et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2521-2532, issn 0028-4793, 12 p.Article

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young ChildrenBEJON, Philip; COOK, Jackie; DUTTA, Sheetij et al.The Journal of infectious diseases. 2011, Vol 204, Num 1, pp 9-18, issn 0022-1899, 10 p.Article

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialOLOTU, Ally; LUSINGU, John; VANSADIA, Preeti et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 2, pp 102-109, issn 1473-3099, 8 p.Article

Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trialAIDE, Pedro; DOBANO, Carlota; HERREROS, Esperanza et al.Vaccine. 2011, Vol 29, Num 35, pp 6059-6067, issn 0264-410X, 9 p.Article

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trialSACARLAL, Jahit; APONTE, John J; OFORI-ANYINAM, Opokua et al.Vaccine. 2008, Vol 26, Num 2, pp 174-184, issn 0264-410X, 11 p.Article

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in InfantsABDULLA, Salim; OBERHOLZER, Rolf; SALIM, Nahya et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2533-2544, issn 0028-4793, 12 p.Article

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children : single-blind extended follow-up of a randomised controlled trialALONSO, Pedro L; SACARLAL, Jahit; GUINOVART, Caterina et al.Lancet (British edition). 2005, Vol 366, Num 9502, pp 2012-2018, issn 0140-6736, 7 p.Article

  • Page / 1